CryoPort Stock News

In the past few years, the CAR-T, gene-based, regenerative medicines sector is becoming prominent.

New York, New York--(Newsfile Corp. - April 8, 2021) - Levi & Korsinsky announces it has commenced an investigation of Cryoport, Inc. (NASDAQ: CYRX) concerning possible breaches of fiduciary duty. To

The stock price of CryoPort, a provider of cold chain logistics solutions for biopharmaceutical companies, has seen a large 22% drop over the last five trading days, but we believe the stock, after th

Cryoport, Inc. (CYRX) CEO Jerrell Shelton on Q4 2020 Results - Earnings Call Transcript

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -86.67% and 11.71%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

NASHVILLE, Tenn., Feb. 25, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indu

NASHVILLE, Tenn., Feb. 25, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indu

2020 was a year unlike any other in the history of the stock market. Despite the dark clouds hanging over the U.S. and global economy, the S&P 500 Index appreciated 16% in the last year, supported by

NASHVILLE, Tenn., Jan. 25, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indu

NASHVILLE, Tenn., Jan. 20, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indu

NASHVILLE, Tenn., Jan. 19, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indu

Both stocks are in the early stage of a long-term growth trajectory.

With the approval of Yescarta and Kymriah in recent years, you are now seeing unprecedented growth in the CAR-T industry. Logistic providers that support CAR-T and gene therapies are profiting from th

Dec.01 -- Cryoport Inc. looks forward to the opportunity to participate in the distribution of the Covid-19 vaccines and admits the logistics will be challenging, Chief Executive Officer Jerrell Shelt

Cryoport's operating model remains insulated via key differentiators in the thermoregulatory logistics domain, with cloud-based integration along the audit chain. Linking with larger players in provid